193 related articles for article (PubMed ID: 35698288)
1. A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro).
Hwangbo Y; Choi JY; Lee EK; Ryu CH; Cho SW; Chung EJ; Hah JH; Jeong WJ; Park SK; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee JY; Lee YJ; Yu HW; Park DJ; Ryu J; Park YJ; Lee KE; Moon JH
Thyroid; 2022 Jul; 32(7):772-780. PubMed ID: 35698288
[No Abstract] [Full Text] [Related]
2. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
[No Abstract] [Full Text] [Related]
3. Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery.
Yoshida Y; Horiuchi K; Okamoto T
Thyroid; 2020 May; 30(5):681-687. PubMed ID: 31910100
[No Abstract] [Full Text] [Related]
4. Surgical Outcomes in Patients With Low-risk Papillary Thyroid Microcarcinoma From MAeSTro Study: Immediate Operation Versus Delayed Operation After Active SurveillanceA Multicenter Prospective Cohort Study.
Hwang H; Choi JY; Yu HW; Moon JH; Kim JH; Lee EK; Kim YK; Lee CY; Cho SW; Chung EJ; Ryu CH; Ryu J; Yi KH; Park DJ; Lee KE; Park YJ; Kim SJ; Jung YS
Ann Surg; 2023 Nov; 278(5):e1087-e1095. PubMed ID: 36912439
[TBL] [Abstract][Full Text] [Related]
5. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
[No Abstract] [Full Text] [Related]
6. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
7. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
Moon JH; Ryu CH; Cho SW; Choi JY; Chung EJ; Hah JH; Hwangbo Y; Jeong WJ; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee EK; Lee JY; Lee KE; Lee YJ; Lee Y; Yu HW; Park DJ; Ryu J; Park YJ
J Clin Endocrinol Metab; 2021 Mar; 106(3):724-735. PubMed ID: 33248442
[TBL] [Abstract][Full Text] [Related]
8. Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
Kim K; Choi JY; Kim SJ; Lee EK; Lee YK; Ryu JS; Lee KE; Moon JH; Park YJ; Cho SW; Park SK
Thyroid; 2022 Jun; 32(6):648-656. PubMed ID: 35570657
[No Abstract] [Full Text] [Related]
9. Longitudinal Assessment of Quality of Life According to Treatment Options in Low-Risk Papillary Thyroid Microcarcinoma Patients: Active Surveillance or Immediate Surgery (Interim Analysis of MAeSTro).
Kong SH; Ryu J; Kim MJ; Cho SW; Song YS; Yi KH; Park DJ; Hwangbo Y; Lee YJ; Lee KE; Kim SJ; Jeong WJ; Chung EJ; Hah JH; Choi JY; Ryu CH; Jung YS; Moon JH; Lee EK; Park YJ
Thyroid; 2019 Aug; 29(8):1089-1096. PubMed ID: 31161898
[No Abstract] [Full Text] [Related]
10. Quality of Life in Patients with Papillary Thyroid Microcarcinoma Managed by Active Surveillance or Lobectomy: A Cross-Sectional Study.
Jeon MJ; Lee YM; Sung TY; Han M; Shin YW; Kim WG; Kim TY; Chung KW; Shong YK; Kim WB
Thyroid; 2019 Jul; 29(7):956-962. PubMed ID: 31038017
[No Abstract] [Full Text] [Related]
11. Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Monteiro E; Chung J; Zahedi A; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2024 May; 34(5):626-634. PubMed ID: 38481111
[No Abstract] [Full Text] [Related]
12. A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Yoannidis T; Rotstein L; Gullane PJ; Gilbert RW; Pasternak JD; Brown DH; Eskander A; Almeida JR; Irish JC; Higgins K; Enepekides DJ; Monteiro E; Banerjee A; Shah M; Gooden E; Zahedi A; Korman M; Ezzat S; Jones JM; Rac VE; Tomlinson G; Stanimirovic A; Gafni A; Baxter NN; Goldstein DP
Thyroid; 2020 Jul; 30(7):999-1007. PubMed ID: 32126932
[No Abstract] [Full Text] [Related]
13. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.
Oda H; Miyauchi A; Ito Y; Yoshioka K; Nakayama A; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):150-5. PubMed ID: 26426735
[TBL] [Abstract][Full Text] [Related]
14. A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.
Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Gooden E; Brown DH; Eskander A; Zahedi A; Chung J; Su J; Xu W; Ihekire O; Jones JM; Gafni A; Baxter NN; Goldstein DP;
Thyroid; 2022 Mar; 32(3):255-262. PubMed ID: 35019770
[No Abstract] [Full Text] [Related]
15. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
Miyauchi A; Ito Y; Fujishima M; Miya A; Onoda N; Kihara M; Higashiyama T; Masuoka H; Kawano S; Sasaki T; Nishikawa M; Fukata S; Akamizu T; Ito M; Nishihara E; Hisakado M; Kosaka K; Hirokawa M; Hayashi T
Thyroid; 2023 Jul; 33(7):817-825. PubMed ID: 37166389
[No Abstract] [Full Text] [Related]
17. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
18. Papillary thyroid microcarcinoma: decision-making, extent of surgery, and outcomes.
Price AK; Randle RW; Schneider DF; Sippel RS; Pitt SC
J Surg Res; 2017 Oct; 218():237-245. PubMed ID: 28985856
[TBL] [Abstract][Full Text] [Related]
19. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].
Liu J; Xu C; Yao X; Zhao R; Zhang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834
[No Abstract] [Full Text] [Related]
20. Active surveillance is an excellent management technique for identifying patients with progressive low-risk papillary thyroid microcarcinoma requiring surgical treatment.
Fujishima M; Miyauchi A; Ito Y; Kudo T; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
Endocr J; 2023 Apr; 70(4):411-418. PubMed ID: 36631086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
